Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Regulatory News (ZTF)

Share Price Information for Zotefoams (ZTF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 574.00
Bid: 564.00
Ask: 576.00
Change: 10.00 (1.77%)
Spread: 12.00 (2.128%)
Open: 564.00
High: 574.00
Low: 564.00
Prev. Close: 564.00
ZTF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MuCell Extrusion LLC Obtains an Exclusive License

14 Aug 2012 07:00

RNS Number : 9308J
Zotefoams PLC
14 August 2012
 



14 August 2012

 

Zotefoams plc

("Zotefoams" or "the Company")

 

 

MuCell Extrusion LLC Obtains an Exclusive License for Styron's

Extruded Styrenic Foam Sheet Patent Portfolio, including Polystyrene, ABS and SAN

 

MuCell Extrusion LLC and Styron (Berwyn, Pennsylvania) have concluded an agreement for MuCell Extrusion LLC to acquire access to Styron's patent portfolio for extrusion of Styrenic resins. This agreement gives MuCell Extrusion and its customers exclusive rights to the Styron patents related to Sheet technology for a wide variety of applications.

 

This agreement creates a significant strategic alliance between two companies with leading experience in the successful development and application of physical blowing agents to produce superior foamed products.

 

The combination of Styron's CO2RE™ technology and MuCell's expertise around technology and hardware is expected to help customers improve their competitive advantage in a shorter timeframe. Sheet for thermoforming, FFS, roll stock, paneling and high volume packaging will all see significant cost reductions by applying this technology.

 

 "CO2RE™ is a patented plastic foaming technology that produces polystyrene sheets with a foamed core layer using physical blowing agents," said John Case, Styrenics Global Marketing Manager, Styron. "The technology provides a good opportunity for the packaging market, where for example dairy and food service industries can improve their sustainability by reducing the density and weight of their product packaging. It also provides benefits in reduced energy and reduced raw material usage, as well as lower packaging waste disposable tax in the EU."

 

"MuCell provides expertise in Process and Equipment development, and Styron offers formulation expertise in resins. We believe this combination will bring significant benefits to our customers," said Mark Lindenfelzer, President of MuCell. "The combination of our own patents and intellectual property, and Styron's patents now gives our customers the opportunity to apply the most advanced foaming technology in their products," he said.

 

About MuCell Technology

MuCell technology is based on the direct injection of atmospheric gas (N2 or CO2) in its supercritical state. MuCell has applied this technology to most plastic materials and processes. Rigid sheet, low-density flexible sheet, Blown film, Cast film, pipe/tubing/profile, and blow molding manufacturing processes are all current applications using MuCell technology. MuCell's innovative and accessible technology brings significant material weight-savings and cost reduction opportunities, without compromising physical product performance.

 

Earlier this year, Dow Chemical and MuCell reached an agreement for MuCell to acquire exclusive rights to Dow's patent portfolio for flat sheet resin technology, and more recently Dow's patents for Foam Film technology.

 

The corporate headquarters of MuCell Extrusion LLC are located at 212 West Cummings Park, Woburn, MA 01810. MuCell Extrusion is a wholly owned subsidiary of Zotefoams plc, UK (ZTF on LSE). For more information, please visit www.mucellextrusion.com.

 

About Styron

Styron is a leading global materials company and manufacturer of plastics, latex and rubber, dedicated to collaborating with customers to deliver innovative and sustainable solutions. Styron's technology is used by customers in industries such as home appliances, automotive, building & construction, carpet, consumer electronics, consumer goods, electrical & lighting, medical, packaging, paper & paperboard, rubber goods and tires. Styron had approximately $6 billion in revenue in 2011, with 20 manufacturing sites around the world, and 2100 employees. More information can be found at www.styron.com.

 

###

 

For Styron editorial information please contact:

Donna St. Germain, Styron

Tel. +1 610 240 3307

stgermain@styron.com

 

 

For information on MuCell Extrusion LLC and Zotefoams plc contact:

 

Zotefoams plc

Clifford Hurst or David Stirling

+44 20 8664 1600

 

FTI Consulting

John Dineen / Victoria Foster Mitchell

+44 20 7831 3113

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBKNDDFBKDPFD
Date   Source Headline
28th Sep 20177:00 amRNSHolding(s) in Company
13th Sep 20177:00 amRNSDirector/PDMR Shareholding
16th Aug 20177:00 amRNSHolding(s) in Company
11th Aug 20175:23 pmRNSHolding(s) in Company
10th Aug 20177:00 amRNSDirector/PDMR Shareholding
8th Aug 20177:00 amRNSDirectorate Changes
8th Aug 20177:00 amRNSHalf-year Report
20th Jul 20177:00 amRNSHolding(s) in Company
12th Jul 201710:19 amRNSDirector/PDMR Shareholding
3rd Jul 20174:35 pmRNSPrice Monitoring Extension
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
5th Jun 20172:14 pmRNSDirector/PDMR Shareholding
1st Jun 20174:30 pmRNSDirector/PDMR Shareholding
31st May 20177:00 amRNSDirector/PDMR Shareholding
17th May 20177:00 amRNSTrading Update
12th May 201711:16 amRNSDirector/PDMR Shareholding
12th Apr 20173:34 pmRNSAnnual Report and Accounts and Notice of 2017 AGM
12th Apr 20173:24 pmRNSDirector/PDMR Shareholding
12th Apr 20171:55 pmRNSHolding(s) in Company
10th Apr 20174:02 pmRNSDirector/PDMR Shareholding
6th Apr 20172:27 pmRNSHolding(s) in Company
6th Apr 20172:25 pmRNSHolding(s) in Company
28th Mar 201711:36 amRNSDirector/PDMR Shareholding
27th Mar 201710:16 amRNSHolding(s) in Company
24th Mar 20173:33 pmRNSHolding(s) in Company
23rd Mar 201710:11 amRNSHolding(s) in Company
22nd Mar 20173:28 pmRNSHolding(s) in Company
14th Mar 20175:28 pmRNSDirector/PDMR Shareholding
14th Mar 20177:00 amRNSFinal Results
9th Mar 20177:00 amRNSCoveris using MuCell® technology
15th Feb 201710:46 amRNSDirector/PDMR Shareholding
10th Feb 20177:00 amRNSHolding(s) in Company
1st Feb 20176:27 pmRNSHolding(s) in Company
12th Jan 20179:36 amRNSDirector/PDMR Shareholding
11th Jan 201710:33 amRNSHolding(s) in Company
10th Jan 20175:34 pmRNSHolding(s) in Company
9th Jan 20177:00 amRNSTrading Update
6th Jan 20177:00 amRNSAppointment of Joint Broker
6th Jan 20177:00 amRNSAcquires full ownership of its joint venture
22nd Dec 20164:35 pmRNSPrice Monitoring Extension
13th Dec 20161:58 pmRNSDirector/PDMR Shareholding
24th Nov 20167:00 amRNSHolding(s) in Company
15th Nov 201612:40 pmRNSDirector/PDMR Shareholding
14th Nov 201610:30 amRNSDirector Declaration
28th Oct 20167:00 amRNSThird Quarter Trading Update
25th Oct 20164:40 pmRNSSecond Price Monitoring Extn
25th Oct 20164:35 pmRNSPrice Monitoring Extension
24th Oct 201612:07 pmRNSSecond Price Monitoring Extn
24th Oct 201612:02 pmRNSPrice Monitoring Extension
20th Oct 20164:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.